Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Role of Klotho G395A Gene Polymorphism in Atherosclerotic Cardiovascular Disease and Mortality Risk Scores in Non-dialysis Chronic Kidney Disease

The Indonesian Biomedical Journal · Vol. 14 No. 3 (2022) · hlm. 294–302

DOI
10.18585/inabj.v14i3.1975
ISSN
2085-3297, 2355-9179
Terbit
2022-09-08
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Klotho expression was reduced in patients with CKD, leading to vascular calcification, endothelial dysfunction, and atherosclerosis. We investigated the role of the klotho G395A gene polymorphism and plasma klotho level in the ten-year risk of atherosclerotic cardiovascular disease (ASCVD) and CVD mortality in CKD patients.METHODS: We used the PCR-CTPP assay method to genotype klotho G395A single nucleotide polymorphism (SNP) in 72 non-dialysis CKD patients. The klotho level was determined using the enzyme-linked immunoassay (ELISA) method. Path analysis was used to determine the relationship between the klotho G395A SNP, plasma klotho level, ASCVD risk score, and CVD mortality risk score.RESULTS: Our results showed that the GA genotype had lower plasma klotho levels than the GG genotype (path coefficient=-0.185, p=0.000). There was a significant negative correlation between plasma klotho level and the ASCVD risk score (r=-0.243, p=0.040), but no significant correlation was found between plasma klotho level and the CVD mortality risk score (r=-0.145, p=0.225). Path analysis showed that plasma klotho level had a significant negative direct effect on ASCVD risk score (path coefficient=-0.272, p=0.000) and an indirect effect on CVD mortality risk score (path coefficient=0.187, p=0.005).CONCLUSION: Klotho G395A SNP might reduce lower plasma klotho levels, which increased ASCVD and CVD mortality risk scores in non-dialysis CKD patients. However, other risk factors such as age, CKD stages, hypertension, and smoking should be taken into consideration. Therefore, large-scale genetic association studies with adjusted variables could be conducted in various ethnic groups for a more robust result.KEYWORDS: klotho, single nucleotide polymorphism, cardiovascular disease, chronic kidney disease

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 183 tautan kepenulisan bersama · 36 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Juntendo University
  • University of Mataram
  • Hasanuddin University
  • University of Surabaya
  • Atma Jaya Catholic University of Indonesia
  • Harvard University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Djoko SantosoUniversitas Airlangga6
Maulana Antiyan EmpituUniversitas Airlangga6
Ika Nindya KadariswantiningsihUniversitas Airlangga6
Cahyo Wibisono NugrohoUniversitas Airlangga6
Zaky Firmawan El-HakimUniversitas Airlangga6
Maulana Muhtadin SuryansyahUniversitas Airlangga6
Yusuke SuzukiJuntendo University6
Lina LukitasariUniversitas Airlangga5
Soetjipto SoetjiptoUniversitas Airlangga4
Ema QurnianingsihUniversitas Airlangga4
Zaskia Nafisa SalmaUniversitas Airlangga4
Rieza Rizqy AldaUniversitas Airlangga4
Mochammad AminUniversitas Airlangga4
Haerani RasyidHasanuddin University4
Romi ErmawanUniversitas Airlangga3
Ira HumairahUniversitas Airlangga3
Siti KhaerunnisaUniversitas Airlangga3
Retno HandajaniUniversitas Airlangga3
Indri SafitriUniversitas Airlangga3
Gwenny Ichsan PrabowoUniversitas Airlangga3
Mulyanto MulyantoUniversity of Mataram2
Widjiati WidjiatiUniversitas Airlangga2
Yudi Her OktavionoUniversitas Airlangga2
Gabriel TandecxiAtma Jaya Catholic University of Indonesia2
Annisa Salsabilla Dwi NugrahaniHarvard University2
Arifa MustikaUniversitas Airlangga2
Much. Muzakky Misbachul FirdausAfiliasi tidak diketahui1
Jordan BakhriansyahUniversity of Surabaya1
Zakiyyatul AflakhaUniversitas Airlangga1
Romadhana Trisnha YomaraUniversitas Airlangga1
Budi UtomoUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The Role of Klotho G395A Gene Polymorphism in Atherosclerotic Cardiovascular Disease and Mortality Risk Scores in Non-dialysis Chronic Kidney Disease</dc:title><dc:creator>Hendri Susilo</dc:creator><dc:creator>Budi Susetyo Pikir</dc:creator><dc:creator>Mochammad Thaha</dc:creator><dc:creator>Mochamad Yusuf Alsagaff</dc:creator><dc:creator>Satriyo Dwi Suryantoro</dc:creator><dc:creator>Citrawati Dyah Kencono Wungu</dc:creator><dc:creator>David Setyo Budi</dc:creator><dc:creator>Laurentius Andre</dc:creator><dc:creator>Cennikon Pakpahan</dc:creator><dc:subject>Klotho</dc:subject><dc:subject>single nucleotide polymorphisms</dc:subject><dc:subject>atherosclerotic cardiovascular disease</dc:subject><dc:subject>cardiovascular mortality</dc:subject><dc:subject>chronic kidney disease</dc:subject><dc:subject>predialysis</dc:subject><dc:subject>cardiovascular risk score</dc:subject><dc:subject>genetic association</dc:subject><dc:description xml:lang="en">BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Klotho expression was reduced in patients with CKD, leading to vascular calcification, endothelial dysfunction, and atherosclerosis. We investigated the role of the klotho G395A gene polymorphism and plasma klotho level in the ten-year risk of atherosclerotic cardiovascular disease (ASCVD) and CVD mortality in CKD patients.METHODS: We used the PCR-CTPP assay method to genotype klotho G395A single nucleotide polymorphism (SNP) in 72 non-dialysis CKD patients. The klotho level was determined using the enzyme-linked immunoassay (ELISA) method. Path analysis was used to determine the relationship between the klotho G395A SNP, plasma klotho level, ASCVD risk score, and CVD mortality risk score.RESULTS: Our results showed that the GA genotype had lower plasma klotho levels than the GG genotype (path coefficient=-0.185, p=0.000). There was a significant negative correlation between plasma klotho level and the ASCVD risk score (r=-0.243, p=0.040), but no significant correlation was found between plasma klotho level and the CVD mortality risk score (r=-0.145, p=0.225). Path analysis showed that plasma klotho level had a significant negative direct effect on ASCVD risk score (path coefficient=-0.272, p=0.000) and an indirect effect on CVD mortality risk score (path coefficient=0.187, p=0.005).CONCLUSION: Klotho G395A SNP might reduce lower plasma klotho levels, which increased ASCVD and CVD mortality risk scores in non-dialysis CKD patients. However, other risk factors such as age, CKD stages, hypertension, and smoking should be taken into consideration. Therefore, large-scale genetic association studies with adjusted variables could be conducted in various ethnic groups for a more robust result.KEYWORDS: klotho, single nucleotide polymorphism, cardiovascular disease, chronic kidney disease</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2022-09-08</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v14i3.1975</dc:identifier><dc:identifier>10.18585/inabj.v14i3.1975</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 14 No 3 (2022); 294-302</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/1975/597</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>